Patrick was President, R&D at GlaxoSmithKline (GSK) from 2012 until 2017. Prior to this, he was Senior Vice President, Medicines Discovery and Development. He joined the company in May 2006 as Head of Drug Discovery. He was a member of the GSK Board and the Corporate Executive Team. During his period as head of R&D over 14 new medicines were approved for use worldwide, for diseases ranging from cancer to asthma and HIV. Prior to joining GSK, he was a clinical academic, Professor of Medicine and led the Division of Medicine at UCL. He has over 20 years’ experience of basic and clinical research, and was a consultant physician in the NHS.